Stock Comparison
GSK vs JNJ
GlaxoSmithKline PLC ADR and Johnson & Johnson side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$102.57B
$626.01B
P/E (TTM)
16.2
30.1
Forward P/E
20.7
22.3
Price/Sales
3.1
6.4
Price/Book
4.3
7.4
EV/EBITDA
9.4
19.3
Dividend Yield
3.43%
2.00%
Profitability
Net Margin
17.78%
21.83%
Operating Margin
25.67%
26.87%
Return on Equity
33.40%
25.70%
Return on Assets
10.00%
8.60%
Growth (YoY)
Revenue Growth
5.30%
6.60%
Earnings Growth
-69.50%
-0.90%
Price & Risk
Beta
0.3
0.2
52-Week High
$60.20
$267.34
52-Week Low
$37.85
$170.46
Analyst Target
$58.08
$272.50
Compare GSK and JNJ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.